![](/img/cover-not-exists.png)
Cross-resistance in the 2′,2′-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs
A.M. Bergman, G. Giaccone, C.J.A. van Moorsel, R. Mauritz, P. Noordhuis, H.M. Pinedo, G.J. PetersVolume:
36
Year:
2000
Language:
english
DOI:
10.1016/s0959-8049(00)00246-x
File:
PDF, 195 KB
english, 2000